This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Altered activity of ancient viral genes were linked to neurodegenerative diseases including ALS in a recent analysis.

Avicenna Biosciences has received its first patent covering new ROCK inhibitor compounds that may be used to treat ...

Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...

Neurosense Therapeutics will meet with the FDA in early November to discuss plans for a Phase 3 trial to test PrimeC in ALS.

Columnist Kristin Neva and her husband with ALS are sometimes asked about the way they went about building their accessible home.

Drinking straws are one of the tools in columnist Dagmar Munn's arsenal to combat dysphagia while living with ALS.

Columnist Kristin Neva is hopeful her nights won't be so hard, now that her husband with ALS can sleep a longer time on his back.

A database with long-term ALS respiratory data has been made available to scientists worldwide, with the goal of accelerating research.

Biotech company Auttx has received a $125,000 grant to advance the development of new molecules that aim to restore normal RNA processing in people with amyotrophic lateral sclerosis (ALS), ...